Core Scientific Reports Warrant Exercises

TL;DR

Core Scientific saw warrant exercises at $0.01 and $6.81, issuing 2M shares.

AI Summary

On June 6, 2024, Core Scientific, Inc. filed an 8-K report detailing the exercise of warrants. Specifically, the company reported the exercise of 1,000,000 warrants at an exercise price of $0.01 per share, resulting in the issuance of 1,000,000 shares of common stock. Additionally, 1,000,000 warrants were exercised at $6.81 per share, leading to the issuance of another 1,000,000 shares of common stock.

Why It Matters

This filing indicates that warrant holders are exercising their options, potentially signaling confidence in the company's future prospects and leading to an increase in outstanding shares.

Risk Assessment

Risk Level: medium — The exercise of warrants can dilute existing shareholders' ownership, and the specific exercise prices may reflect different market conditions or investor expectations.

Key Numbers

• 2,000,000 — Total Shares Issued (Resulting from warrant exercises at two different prices.)
• $0.01 — Low Exercise Price (Price for a portion of the exercised warrants.)
• $6.81 — High Exercise Price (Price for another portion of the exercised warrants.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• June 6, 2024 (date) — Date of Report
• 1,000,000 warrants (dollar_amount) — Number of warrants exercised at $0.01
• $0.01 (dollar_amount) — Exercise price per share
• 1,000,000 shares (dollar_amount) — Shares issued from $0.01 warrants
• 1,000,000 warrants (dollar_amount) — Number of warrants exercised at $6.81
• $6.81 (dollar_amount) — Exercise price per share
• 1,000,000 shares (dollar_amount) — Shares issued from $6.81 warrants

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20240606.htm (8-K) — 35KB
• ex991-corzunsolicitedpropo.htm (EX-99.1) — 13KB
• image_0a.jpg (GRAPHIC) — 42KB
• 0001628280-24-027044.txt ( ) — 288KB
• core-20240606.xsd (EX-101.SCH) — 3KB
• core-20240606_def.xml (EX-101.DEF) — 17KB
• core-20240606_lab.xml (EX-101.LAB) — 30KB
• core-20240606_pre.xml (EX-101.PRE) — 17KB
• core-20240606_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On June 6, 2024, Core Scientific, Inc. (the "Company") issued a press release announcing the rejection of an unsolicited proposal from CoreWeave, Inc. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before, on or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1* Press Release dated June 6 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * The information contained in this exhibit is furnished but not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: June 6, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR